Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Salt Lake City. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Salt Lake City location
Preparing your pre-screening questions…
Access head and neck cancer specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
Check if you qualify for this head and neck cancer clinical trial in Salt Lake City, UT
No-Cost Study Care
Local to Salt Lake City
Convenient for UT residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Tumor hypoxia is one of the physiological factors for treatment resistance and likely contributes to poor overall survival among patients with head and neck cancer (HNC). Identifying hypoxic features of HNC may allow the personalizing treatment plan. The investigators propose multiparametric Hypoxia MR (HMR) imaging using diffusion, perfusion, and oxygenation as non-invasive, in-vivo imaging components of a hypoxia phenotype. Assessing the hypoxia phenotypes' expression will be critically important for characterizing and predicting CRT response among patients with advanced HNC. A prospective cohort study will be conducted used multiparametric MR (MPMR) imaging correlated with treatment response assessed by 3 months fluorodeoxyglucose-positron emission tomography (FDG-PET). The image analysis approach will be developed to incorporate FDG-PET and quantitative MRI characteristics of tumor (ADC, oxygen-enhanced T1 and T2\* maps, and volume transfer constant (Ktrans) to facilitate 3D visualization of multiparametric information. This proposed study's overarching goal is to develop and validate multiparametric HMR imaging using 18F - (fluoromisonidazole) FMISO-PET and immunohistochemistry (IHC) as the standard of references.
Sponsor: University of Utah
Yes, this clinical trial (NCT06108089) has an active research site in Salt Lake City, UT that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for head and neck cancer treatment options in Salt Lake City, UT, this clinical trial (NCT06108089) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Salt Lake City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all head and neck cancer clinical trials near you to find additional studies recruiting in your area.
See all head and neck cancer clinical trials recruiting in Salt Lake City — not just this study.
Browse Head and Neck Cancer Trials in Salt Lake City →